Alnylam Re-Negotiates RNAi Patent from Max Planck Society, Freeing it from Obligation to Maintain Jobs in Germany | GenomeWeb

NEW YORK, June 16 (GenomeWeb News) - Alnylam has amended its exclusive license of an RNAi patent application from the Max Planck Society, freeing it from certain obligations to maintain jobs and facilities in Germany, the company said today.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.